<code id='3A9D6168A7'></code><style id='3A9D6168A7'></style>
    • <acronym id='3A9D6168A7'></acronym>
      <center id='3A9D6168A7'><center id='3A9D6168A7'><tfoot id='3A9D6168A7'></tfoot></center><abbr id='3A9D6168A7'><dir id='3A9D6168A7'><tfoot id='3A9D6168A7'></tfoot><noframes id='3A9D6168A7'>

    • <optgroup id='3A9D6168A7'><strike id='3A9D6168A7'><sup id='3A9D6168A7'></sup></strike><code id='3A9D6168A7'></code></optgroup>
        1. <b id='3A9D6168A7'><label id='3A9D6168A7'><select id='3A9D6168A7'><dt id='3A9D6168A7'><span id='3A9D6168A7'></span></dt></select></label></b><u id='3A9D6168A7'></u>
          <i id='3A9D6168A7'><strike id='3A9D6168A7'><tt id='3A9D6168A7'><pre id='3A9D6168A7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:8877
          Micky Tripathi Office of the National Coordinator for Health Information Technology

          Micky Tripathi is equal parts excited — and deeply concerned — about the technological change sweeping through medicine.

          As adoption of generative AI races ahead,  his job as National Coordinator for Health Information Technology under President Joe Biden is to manage this change, and keep it safe and organized. But how do you organize a pell-mell rush? How do you keep chaos safe?

          advertisement

          “It’s definitely changed my life,” Tripathi said of his official remit, which also led to his appointment as co-chair of a task force on AI within the Department of Health and Human Services.  “We believe it’s really, really important that we be out ahead of this.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          Insmed lung disease drug hits target in key Phase 3 trial
          Insmed lung disease drug hits target in key Phase 3 trial

          AdobeAnexperimentaldrugfromInsmedIncorporatedsuccessfullyreducedlungproblemsamongpatientswithanairwa

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Testing GLP

          NoraVolkow(right)saidinaconversationwithSTAT'sElaineChen:“Thisisastructuralproblemthatwehave:Thatwe’